EA200970332A1 - Новые антигены и антитела, ассоциированные с аденокарциномой панкреатического протока - Google Patents
Новые антигены и антитела, ассоциированные с аденокарциномой панкреатического протокаInfo
- Publication number
- EA200970332A1 EA200970332A1 EA200970332A EA200970332A EA200970332A1 EA 200970332 A1 EA200970332 A1 EA 200970332A1 EA 200970332 A EA200970332 A EA 200970332A EA 200970332 A EA200970332 A EA 200970332A EA 200970332 A1 EA200970332 A1 EA 200970332A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- pancreatic
- antibodies
- pda
- adhenocarcinoma
- identified
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57438—Specifically defined cancers of liver, pancreas or kidney
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y402/00—Carbon-oxygen lyases (4.2)
- C12Y402/01—Hydro-lyases (4.2.1)
- C12Y402/01011—Phosphopyruvate hydratase (4.2.1.11), i.e. enolase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/988—Lyases (4.), e.g. aldolases, heparinase, enolases, fumarase
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Engineering & Computer Science (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Gastroenterology & Hepatology (AREA)
- Cell Biology (AREA)
- Oncology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Toxicology (AREA)
- Peptides Or Proteins (AREA)
Abstract
Настоящее изобретение относится к новым белковым антигенам человека и соответствующим антителам, которые были идентифицированы как специфически экспрессируемые в ассоциации с аденокарциномой панкреатического протока человека (PDA). В частности, идентифицированы новые фосфорилированные изоформы альфа-енолазы в трансформированных клеточных линиях панкреатического происхождения и антитела, связывающие такие изоформы, которые присутствуют специфически в сыворотках пациентов с PDA. Указанные белки и антитела могут использоваться для диагностики и лечения PDA и других видов рака, которые характеризуются соответствующими, близкими к рассматриваемым молекулярными особенностями.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06121552 | 2006-09-29 | ||
EP06126726 | 2006-12-20 | ||
PCT/EP2007/060305 WO2008037792A1 (en) | 2006-09-29 | 2007-09-28 | Novel antigens and antibodies associated to pancreatic ductal adenocarcinoma |
Publications (2)
Publication Number | Publication Date |
---|---|
EA200970332A1 true EA200970332A1 (ru) | 2009-10-30 |
EA016731B1 EA016731B1 (ru) | 2012-07-30 |
Family
ID=38895810
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200970332A EA016731B1 (ru) | 2006-09-29 | 2007-09-28 | Изоформа человеческой альфа-енолазы, антитело к указанной изоформе и способы их применения |
Country Status (18)
Country | Link |
---|---|
US (1) | US8071721B2 (ru) |
EP (1) | EP2069395B1 (ru) |
JP (1) | JP2010505104A (ru) |
KR (1) | KR20090094227A (ru) |
CN (1) | CN101578295B (ru) |
AT (1) | ATE542831T1 (ru) |
AU (1) | AU2007301966B2 (ru) |
BR (1) | BRPI0717282A2 (ru) |
CA (1) | CA2664841A1 (ru) |
DK (1) | DK2069395T3 (ru) |
EA (1) | EA016731B1 (ru) |
ES (1) | ES2381304T3 (ru) |
IL (2) | IL197868A (ru) |
NO (1) | NO20091662L (ru) |
NZ (1) | NZ576409A (ru) |
PL (1) | PL2069395T3 (ru) |
PT (1) | PT2069395E (ru) |
WO (1) | WO2008037792A1 (ru) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2277049A4 (en) * | 2008-05-09 | 2012-05-30 | Univ Duke | AUTOANTIBODIES IN THE DETECTION AND TREATMENT OF CANCER |
IT1398782B1 (it) | 2009-09-11 | 2013-03-18 | Novelli | Peptide monofosforilato isolato derivato dall'alfa-enolasi umana utile per la diagnosi e il trattamento dell'adenocarcinoma pancreatico, anticorpi diretti contro il suddetto peptide monofosforilato e loro usi. |
ITTO20120523A1 (it) * | 2012-06-15 | 2013-12-16 | Natimab Therapeutics S R L | Procedimento e kit per la diagnosi in vitro dell'adenocarcinoma duttale pancreatico o per determinare la predisposizione all'adenocarcinoma duttale pancreatico |
EP3083697B1 (en) * | 2013-12-20 | 2019-04-17 | Development Center for Biotechnology | Alpha-enolase specific antibodies and methods of uses in cancer therapy |
BR112016016153A2 (pt) | 2014-01-13 | 2017-12-12 | Berg Llc | composições de enolase 1 (eno1) e usos das mesmas |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5753446A (en) * | 1993-04-15 | 1998-05-19 | National Jewish Center For Immunology & Respiratory Medicine | Mitogen ERK kinase kinase (MEKK) assay |
-
2007
- 2007-09-28 PL PL07820692T patent/PL2069395T3/pl unknown
- 2007-09-28 DK DK07820692.7T patent/DK2069395T3/da active
- 2007-09-28 NZ NZ576409A patent/NZ576409A/en not_active IP Right Cessation
- 2007-09-28 KR KR1020097008777A patent/KR20090094227A/ko not_active Application Discontinuation
- 2007-09-28 WO PCT/EP2007/060305 patent/WO2008037792A1/en active Application Filing
- 2007-09-28 CN CN2007800423663A patent/CN101578295B/zh not_active Expired - Fee Related
- 2007-09-28 US US12/443,576 patent/US8071721B2/en not_active Expired - Fee Related
- 2007-09-28 AU AU2007301966A patent/AU2007301966B2/en not_active Ceased
- 2007-09-28 PT PT07820692T patent/PT2069395E/pt unknown
- 2007-09-28 JP JP2009529713A patent/JP2010505104A/ja active Pending
- 2007-09-28 BR BRPI0717282-6A patent/BRPI0717282A2/pt not_active IP Right Cessation
- 2007-09-28 EA EA200970332A patent/EA016731B1/ru not_active IP Right Cessation
- 2007-09-28 ES ES07820692T patent/ES2381304T3/es active Active
- 2007-09-28 CA CA002664841A patent/CA2664841A1/en not_active Abandoned
- 2007-09-28 AT AT07820692T patent/ATE542831T1/de active
- 2007-09-28 EP EP07820692A patent/EP2069395B1/en active Active
-
2009
- 2009-03-26 IL IL197868A patent/IL197868A/en not_active IP Right Cessation
- 2009-04-27 NO NO20091662A patent/NO20091662L/no not_active Application Discontinuation
-
2012
- 2012-03-01 IL IL218442A patent/IL218442A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
EA016731B1 (ru) | 2012-07-30 |
BRPI0717282A2 (pt) | 2013-10-15 |
CN101578295A (zh) | 2009-11-11 |
CN101578295B (zh) | 2013-02-27 |
US20100028907A1 (en) | 2010-02-04 |
AU2007301966B2 (en) | 2013-02-21 |
AU2007301966A1 (en) | 2008-04-03 |
NO20091662L (no) | 2009-06-29 |
PT2069395E (pt) | 2012-04-27 |
ES2381304T3 (es) | 2012-05-25 |
DK2069395T3 (da) | 2012-05-14 |
KR20090094227A (ko) | 2009-09-04 |
IL197868A0 (en) | 2011-08-01 |
PL2069395T3 (pl) | 2012-06-29 |
CA2664841A1 (en) | 2008-04-03 |
IL197868A (en) | 2013-03-24 |
JP2010505104A (ja) | 2010-02-18 |
IL218442A0 (en) | 2012-04-30 |
NZ576409A (en) | 2012-02-24 |
EP2069395B1 (en) | 2012-01-25 |
EP2069395A1 (en) | 2009-06-17 |
WO2008037792A1 (en) | 2008-04-03 |
ATE542831T1 (de) | 2012-02-15 |
US8071721B2 (en) | 2011-12-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY162056A (en) | Diagnosis and treatment of cancer using anti -ereg antibody | |
CY1118979T1 (el) | Αντισωματα που κατευθυνονται εναντι her-3 και χρησεις αυτων | |
TR201910348T4 (tr) | Matriks metalloproteinaz 9 için antikorlar. | |
MX2009013824A (es) | Proteinas de enlace de antigeno que enlazan par-2. | |
CY1117437T1 (el) | Αντισωματα αντι-μεσοθηλινης και χρησεις αυτων | |
EA201492253A1 (ru) | Конструкторы, связывающиеся с ron, и способы их использования | |
CY1117236T1 (el) | Μονοκλωνικα αντισωματα εναντι γλυπικανης-3 | |
CY1119539T1 (el) | Πληρως ανθρωπινα αντισωματα ειδικα για to cadμ1 | |
MY150400A (en) | Antibodies that bind human protein tyrosine phosphatase beta (hptpbeta) and uses thereof | |
MX2008009886A (es) | Anticuerpos que enlazan par-2. | |
ATE504602T1 (de) | Für humane matriptase spezifische bindungsproteine | |
EA201000424A1 (ru) | Антитела к il-23 | |
WO2012097313A3 (en) | Therapeutic antibodies against ror-1 protein and methods for use of same | |
MX2009006277A (es) | Anticuerpos humanos que se enlazan a cd70 y usos de los mismos. | |
EA200702361A1 (ru) | АНТИТЕЛА ПРОТИВ csPCNA ИЗОФОРМЫ И ИХ ПРИМЕНЕНИЕ | |
BRPI0808940A8 (pt) | anticorpo humano ou fragmento de ligação do mesmo, antígeno, polinucleotídeo, vetor, célula hospedeira, método para preparar um anticorpo ou um fragmento de ligação ou cadeia(s) de imunoglobulina do mesmo, anticorpo, cadeia de imunoglobulina ou um fragmento de ligação do mesmo, composição, usos do anticorpo ou fragmento de ligação, de um antígeno, de um polinucleotídeo, de um vetor, ou de uma célula, e de uma molécula de ligação a antígeno tumoral, método para clonagem molecular de um anticorpo, e, kit para o diagnóstico de um tumor | |
TN2011000528A1 (en) | Compositions and methods for antibodies targeting complement protein c3b | |
UA99602C2 (ru) | Антитело, специфически связывающееся с jam-a, способное ингибировать пролиферацию опухолевых клеток | |
EA201070179A1 (ru) | Антиген, связанный с вариантами рака легкого и лимфомами | |
IL218442A0 (en) | Novel antigens and antibodies associated to pancreatic ductal adenocarcinoma | |
BR112012024997A2 (pt) | peptídeos ect2 e vacinas incluindo os mesmos | |
BR112012022641A2 (pt) | peptídeos hjurp e vacinas que incluem os mesmos | |
MY192517A (en) | Antibody specifically binding to pauf protein and use thereof | |
WO2006133145A3 (en) | Tat-007 and methods of assessing and treating cancer | |
WO2006116681A3 (en) | Tat-003 and methods of assessing and treating cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM RU |